Association of Common Variants in HNF1A Gene with Serum AFP Level in Healthy Chinese Individuals and HCC Patients
Although alpha-fetoprotein (AFP) is a widely used tumor marker in hepatocellular carcinoma (HCC), 40% of newly diagnosed patients do not have an elevated AFP level. Research has revealed that mutations in the HNF1A binding site of the AFP gene promoter cause significantly elevated serum AFP levels i...
Main Authors: | Xue-jun Li, Dong-hua Shao, Mei-lin He, Guo-wei Liang |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2019-01-01
|
Series: | Disease Markers |
Online Access: | http://dx.doi.org/10.1155/2019/6273497 |
Similar Items
-
Upregulation of Serum Sphingosine (d18:1)-1-P Potentially Contributes to Distinguish HCC Including AFP-Negative HCC From Cirrhosis
by: Yingying Jiang, et al.
Published: (2020-09-01) -
Investigation of Potential Molecular Biomarkers for Diagnosis and Prognosis of AFP-Negative HCC
by: Liu Z, et al.
Published: (2021-08-01) -
AFP ratio predicts HCC recurrence after liver transplantation.
by: Christine Koch, et al.
Published: (2020-01-01) -
A cross sectional analysis of the association between FGF19 tumor expression and serum AFP levels in advanced HCC patients
by: Clifford, Corinne
Published: (2017) -
Heterogeneities of Site-Specific N-Glycosylation in HCC Tumors With Low and High AFP Concentrations
by: Ting Zhao, et al.
Published: (2020-04-01)